메뉴 건너뛰기




Volumn 33, Issue 23, 2012, Pages 2939-2945

Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe

Author keywords

Atherosclerosis; Lipids; Risk factors

Indexed keywords

C REACTIVE PROTEIN; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL;

EID: 84866244324     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs105     Document Type: Article
Times cited : (18)

References (31)
  • 4
    • 34548644843 scopus 로고    scopus 로고
    • Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane
    • Knopfel M, Davies JP, Duong PT, Kvaerno L, Carreira EM, Phillips MC, Ioannou YA, Hauser H. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane. Biochim Biophys Acta 2007;1771:1140-1147.
    • (2007) Biochim Biophys Acta , vol.1771 , pp. 1140-1147
    • Knopfel, M.1    Davies, J.P.2    Duong, P.T.3    Kvaerno, L.4    Carreira, E.M.5    Phillips, M.C.6    Ioannou, Y.A.7    Hauser, H.8
  • 5
    • 34548620629 scopus 로고    scopus 로고
    • Class B type i scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles
    • Labonte ED, Howles PN, Granholm NA, Rojas JC, Davies JP, Ioannou YA, Hui DY. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles. Biochim Biophys Acta 2007;1771:1132-1139.
    • (2007) Biochim Biophys Acta , vol.1771 , pp. 1132-1139
    • Labonte, E.D.1    Howles, P.N.2    Granholm, N.A.3    Rojas, J.C.4    Davies, J.P.5    Ioannou, Y.A.6    Hui, D.Y.7
  • 6
    • 34548635540 scopus 로고    scopus 로고
    • Ezetimibe in search of receptor(s)-still a never-ending challenge in cholesterol absorption and transport
    • Spener F. Ezetimibe in search of receptor(s)-still a never-ending challenge in cholesterol absorption and transport. Biochim Biophys Acta 2007;1771: 1113-1116.
    • (2007) Biochim Biophys Acta , vol.1771 , pp. 1113-1116
    • Spener, F.1
  • 7
    • 26444537961 scopus 로고    scopus 로고
    • Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe
    • During A, Dawson HD, Harrison EH. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J Nutr 2005;135:2305-2312.
    • (2005) J Nutr , vol.135 , pp. 2305-2312
    • During, A.1    Dawson, H.D.2    Harrison, E.H.3
  • 8
    • 75749114117 scopus 로고    scopus 로고
    • Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: Comparative study between simvastatin and simvastatin/ezetimibe coadministration
    • Araujo DB, Bertolami MC, Ferreira WP, Abdalla DS, Faludi AA, Nakamura Y, Bricharello LP. Pleiotropic effects with equivalent low-density lipoprotein cholesterol reduction: comparative study between simvastatin and simvastatin/ezetimibe coadministration. J Cardiovasc Pharmacol 2010;55:1-5.
    • (2010) J Cardiovasc Pharmacol , vol.55 , pp. 1-5
    • Araujo, D.B.1    Bertolami, M.C.2    Ferreira, W.P.3    Abdalla, D.S.4    Faludi, A.A.5    Nakamura, Y.6    Bricharello, L.P.7
  • 9
    • 26044473080 scopus 로고    scopus 로고
    • Endothelial function in the forearm circulation of patients with the metabolic syndrome-effect of different lipid-lowering regimens
    • Bulut D, Hanefeld C, Bulut-Streich N, Graf C, Mugge A, Spiecker M. Endothelial function in the forearm circulation of patients with the metabolic syndrome-effect of different lipid-lowering regimens. Cardiology 2005;104:176-180.
    • (2005) Cardiology , vol.104 , pp. 176-180
    • Bulut, D.1    Hanefeld, C.2    Bulut-Streich, N.3    Graf, C.4    Mugge, A.5    Spiecker, M.6
  • 10
    • 33646740966 scopus 로고    scopus 로고
    • Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: Clinical evidence for 'pleiotropic' functions of statin therapy
    • Fichtlscherer S, Schmidt-Lucke C, Bojunga S, Rossig L, Heeschen C, Dimmeler S, Zeiher AM. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy. Eur Heart J 2006;27:1182-1190.
    • (2006) Eur Heart J , vol.27 , pp. 1182-1190
    • Fichtlscherer, S.1    Schmidt-Lucke, C.2    Bojunga, S.3    Rossig, L.4    Heeschen, C.5    Dimmeler, S.6    Zeiher, A.M.7
  • 12
    • 77952292502 scopus 로고    scopus 로고
    • Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe
    • Kater AL, Batista MC, Ferreira SR. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe. Metabolism 2010; 59:921-926.
    • (2010) Metabolism , vol.59 , pp. 921-926
    • Kater, A.L.1    Batista, M.C.2    Ferreira, S.R.3
  • 13
    • 79953331260 scopus 로고    scopus 로고
    • Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients
    • Kawagoe Y, Hattori Y, Nakano A, Aoki C, Tanaka S, Ohta S, Iijima T, Tomizawa A, Jojima T, Kase H, Kasai K. Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients. Endocr J 2011;58:171-175.
    • (2011) Endocr J , vol.58 , pp. 171-175
    • Kawagoe, Y.1    Hattori, Y.2    Nakano, A.3    Aoki, C.4    Tanaka, S.5    Ohta, S.6    Iijima, T.7    Tomizawa, A.8    Jojima, T.9    Kase, H.10    Kasai, K.11
  • 15
    • 59049103155 scopus 로고    scopus 로고
    • Evidence for statin pleiotropy in humans: Differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation
    • Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2009; 119:131-138.
    • (2009) Circulation , vol.119 , pp. 131-138
    • Liu, P.Y.1    Liu, Y.W.2    Lin, L.J.3    Chen, J.H.4    Liao, J.K.5
  • 16
    • 67349105071 scopus 로고    scopus 로고
    • Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: Results of the CEZAR study
    • Ostad MA, Eggeling S, Tschentscher P, Schwedhelm E, Boger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. Atherosclerosis 2009;205:227-232.
    • (2009) Atherosclerosis , vol.205 , pp. 227-232
    • Ostad, M.A.1    Eggeling, S.2    Tschentscher, P.3    Schwedhelm, E.4    Boger, R.5    Wenzel, P.6    Meinertz, T.7    Munzel, T.8    Warnholtz, A.9
  • 17
    • 77954314232 scopus 로고    scopus 로고
    • Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy
    • Schmidt-Lucke C, Fichtlscherer S, Rossig L, Kamper U, Dimmeler S. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 2010;211:249-254.
    • (2010) Atherosclerosis , vol.211 , pp. 249-254
    • Schmidt-Lucke, C.1    Fichtlscherer, S.2    Rossig, L.3    Kamper, U.4    Dimmeler, S.5
  • 18
    • 47649116533 scopus 로고    scopus 로고
    • Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease
    • Settergren M, Bohm F, Ryden L, Pernow J. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J 2008;29:1753-1760.
    • (2008) Eur Heart J , vol.29 , pp. 1753-1760
    • Settergren, M.1    Bohm, F.2    Ryden, L.3    Pernow, J.4
  • 22
    • 77953121328 scopus 로고    scopus 로고
    • The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): Final results and the impact of medication adherence, dose, and treatment duration
    • Villines TC, Stanek EJ, Devine PJ, Turco M, Miller M, Weissman NJ, Griffen L, Taylor AJ. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration. J Am Coll Cardiol 2010;55:2721-2726.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 2721-2726
    • Villines, T.C.1    Stanek, E.J.2    Devine, P.J.3    Turco, M.4    Miller, M.5    Weissman, N.J.6    Griffen, L.7    Taylor, A.J.8
  • 23
    • 34249304476 scopus 로고    scopus 로고
    • Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS)
    • Devine PJ, Turco MA, Taylor AJ. Design and rationale of the ARBITER 6 trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)-6-HDL and LDL Treatment Strategies in Atherosclerosis (HALTS). Cardiovasc Drugs Ther 2007;21:221-225.
    • (2007) Cardiovasc Drugs Ther , vol.21 , pp. 221-225
    • Devine, P.J.1    Turco, M.A.2    Taylor, A.J.3
  • 24
    • 38549168453 scopus 로고    scopus 로고
    • Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on noncholesterol sterols in patients with primary hypercholesterolemia
    • Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on noncholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin 2008;24:249-259.
    • (2008) Curr Med Res Opin , vol.24 , pp. 249-259
    • Assmann, G.1    Kannenberg, F.2    Ramey, D.R.3    Musliner, T.A.4    Gutkin, S.W.5    Veltri, E.P.6
  • 25
    • 30844437481 scopus 로고    scopus 로고
    • Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: Effects on plasma lipid levels
    • Jakulj L, Trip MD, Sudhop T, von BK, Kastelein JJ, Vissers MN. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J Lipid Res 2005;46: 2692-2698.
    • (2005) J Lipid Res , vol.46 , pp. 2692-2698
    • Jakulj, L.1    Trip, M.D.2    Sudhop, T.3    Von, B.K.4    Kastelein, J.J.5    Vissers, M.N.6
  • 26
    • 77954320146 scopus 로고    scopus 로고
    • Ezetimibe alone or in combination with simvastatin increases small dense lowdensity lipoproteins in healthy men: A randomized trial
    • Berneis K, Rizzo M, Berthold HK, Spinas GA, Krone W, Gouni-Berthold I. Ezetimibe alone or in combination with simvastatin increases small dense lowdensity lipoproteins in healthy men: a randomized trial. Eur Heart J 2010;31: 1633-1639.
    • (2010) Eur Heart J , vol.31 , pp. 1633-1639
    • Berneis, K.1    Rizzo, M.2    Berthold, H.K.3    Spinas, G.A.4    Krone, W.5    Gouni-Berthold, I.6
  • 27
    • 33646073444 scopus 로고    scopus 로고
    • Effect of ezetimibe on low-density lipoprotein subtype distribution: Results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins
    • Geiss HC, Otto C, Parhofer KG. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Metabolism 2006; 55:599-604.
    • (2006) Metabolism , vol.55 , pp. 599-604
    • Geiss, H.C.1    Otto, C.2    Parhofer, K.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.